FDA gets comments on track/trace plan; Pharma drives job creation in India;

> Interoperability, coding, data management and authentication top the areas of concern mentioned by stakeholders in response to the FDA's track-and-trace system plan. Story

> Pharma is among the top sectors contributing to the creation of 1.6 million jobs in India 2011, up from 1.13 million in 2010. Story

> Drugmakers face tightening cold chain requirements of national health authorities, notably Brazil, South Korea and Turkey. Story

> Packaging footprint, as well as recyclability and alternatives to PVC and BPA, are currently on the minds of drugmakers. Interview

> Taro Pharmaceutical Industries says it has regained an acceptable regulatory status for its plant in Brampton, Ontario, Canada following an FDA re-inspection. Item

> India's finance ministry and its drug price watchdog disagree over whether industry or consumers should be beneficiaries of a partial excise duty waiver in Jammu and Kashmir. Story

> PREDICT, the FDA's web-based screening program for food and drug imports, is back on track after a setback caused by software problems. Article

> Both Pall and Sartorius Stedim have unveiled single-use aseptic disconnectors. Pall release | Sartorius Stedim release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.